[The most important study results concerning nonsurgical primary treatment of locally advanced head and neck cancer: Highlights of the ASCO Meeting 2015].

Gliese, A; Busch, C-J; Knecht, R

[The most important study results concerning nonsurgical primary treatment of locally advanced head and neck cancer: Highlights of the ASCO Meeting 2015]. / Die wichtigsten Studienergebnisse zur nichtchirurgischen Primärtherapie lokal fortgeschrittener KopfHalsTumoren: Highlights des ASCO-Kongresses 2015.

Gliese, A; Busch, C-J; Knecht, R.

Affiliation

Gliese A; Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde, Kopf-Hals-Chirurgie und Onkologie, Universitäres Cancer Center Hamburg, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland.

HNO ; 63(9): 606-11, 2015 Sep.

Article in De | MEDLINE | ID: mdl-26303521

Subject(s)

Antibodies, Monoclonal/administration & dosage; Carboplatin/administration & dosage; Chemoradiotherapy/methods; Cisplatin/administration & dosage; Head and Neck Neoplasms/pathology; Head and Neck Neoplasms/therapy; Drug Administration Schedule; Humans; Molecular Targeted Therapy/methods; Neoplasm Invasiveness; Otorhinolaryngologic Surgical Procedures; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carboplatin / Cisplatin / Chemoradiotherapy / Head and Neck Neoplasms / Antibodies, Monoclonal Limits: Humans Language: De Journal: HNO Year: 2015 Type: Article

Fulltext

XML

PubMed Links

Search on Google